<DOC>
	<DOCNO>NCT00359008</DOCNO>
	<brief_summary>The primary objective study assess ability PHP &amp; HPHP detect newly diagnose non treat Chorodial neovascularization ( CNV ) lesion associate advance age relate Macular Degeneration ( AMD ) differentiate Early/intermediate/GA AMD</brief_summary>
	<brief_title>PHP Home Preferential Hyperacuity Perimeter Detection Choroidal Neovascularization ( CNV )</brief_title>
	<detailed_description>study prospective , multi-center , comparative The PHP class I FDA approve Device ( K050350 )</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<criteria>Patients AMD related lesion : Newly diagnose ( 6 month ) nontreated CNV patient secondary AMD study eye , GA patient Early Intermediate AMD patient . Age Â³ 50 AMD patient VA habitual correction study eye 6/60 good Mental physical ability perform PHP/HPHP test Subject able willing sign consent form participate study Subject participate another study conduct test Evidence macular disease AMD Glaucoma study eye . Presence significant medium opacity precludes clear view macular area identify biomicroscopy , fundus photography , fluorescein angiography study eye Any nonmacular relate ocular surgery perform within 3 month prior study study eye CNV patient inability tolerate intravenous fluorescein angiography</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>AMD</keyword>
	<keyword>CNV</keyword>
	<keyword>PHP</keyword>
</DOC>